These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 11388743)
1. Different growth factor requirements for the ex vivo amplification of transplantable human cord blood cells in a NOD/SCID mouse model. Bruno S; Gammaitoni L; Gunetti M; Sanavio F; Fagioli F; Aglietta M; Piacibello W J Biol Regul Homeost Agents; 2001; 15(1):38-48. PubMed ID: 11388743 [TBL] [Abstract][Full Text] [Related]
2. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells. Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951 [TBL] [Abstract][Full Text] [Related]
3. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells. Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558 [TBL] [Abstract][Full Text] [Related]
4. Identification of growth factor conditions that reduce ex vivo cord blood progenitor expansion but do not alter human repopulating cell function in vivo. Levac K; Karanu F; Bhatia M Haematologica; 2005 Feb; 90(2):166-72. PubMed ID: 15710567 [TBL] [Abstract][Full Text] [Related]
5. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. Ueda T; Tsuji K; Yoshino H; Ebihara Y; Yagasaki H; Hisakawa H; Mitsui T; Manabe A; Tanaka R; Kobayashi K; Ito M; Yasukawa K; Nakahata T J Clin Invest; 2000 Apr; 105(7):1013-21. PubMed ID: 10749580 [TBL] [Abstract][Full Text] [Related]
6. Role of different medium and growth factors on placental blood stem cell expansion: an in vitro and in vivo study. Berger M; Fagioli F; Piacibello W; Sanavio F; Mareschi K; Biasin E; Bruno S; Gammaitoni L; Gunetti M; Nesi F; Madon E; Aglietta M Bone Marrow Transplant; 2002 Mar; 29(5):443-8. PubMed ID: 11919735 [TBL] [Abstract][Full Text] [Related]
7. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture. Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520 [TBL] [Abstract][Full Text] [Related]
8. Fast but durable megakaryocyte repopulation and platelet production in NOD/SCID mice transplanted with ex-vivo expanded human cord blood CD34+ cells. Bruno S; Gunetti M; Gammaitoni L; Perissinotto E; Caione L; Sanavio F; Fagioli F; Aglietta M; Piacibello W Stem Cells; 2004; 22(2):135-43. PubMed ID: 14990853 [TBL] [Abstract][Full Text] [Related]
9. Support of hMSCs transduced with TPO/FL genes to expansion of umbilical cord CD34+ cells in indirect co-culture. Xie C; Jia B; Xiang Y; Wang L; Wang G; Huang G; McNiece IK; Wang J Cell Tissue Res; 2006 Oct; 326(1):101-10. PubMed ID: 16685532 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo megakaryocyte differentiation of fresh and ex-vivo expanded cord blood cells: rapid and transient megakaryocyte reconstitution. Bruno S; Gunetti M; Gammaitoni L; Danè A; Cavalloni G; Sanavio F; Fagioli F; Aglietta M; Piacibello W Haematologica; 2003 Apr; 88(4):379-87. PubMed ID: 12681964 [TBL] [Abstract][Full Text] [Related]
11. Ex vivo culture of human CD34+ cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model. van Hensbergen Y; Schipper LF; Brand A; Slot MC; Welling M; Nauta AJ; Fibbe WE Exp Hematol; 2006 Jul; 34(7):943-50. PubMed ID: 16797422 [TBL] [Abstract][Full Text] [Related]
12. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice. Fei XM; Wu YJ; Chang Z; Miao KR; Tang YH; Zhou XY; Wang LX; Pan QQ; Wang CY Cytotherapy; 2007; 9(4):338-47. PubMed ID: 17573609 [TBL] [Abstract][Full Text] [Related]
13. Negative influence of IL3 on the expansion of human cord blood in vivo long-term repopulating stem cells. Piacibello W; Gammaitoni L; Bruno S; Gunetti M; Fagioli F; Cavalloni G; Aglietta M J Hematother Stem Cell Res; 2000 Dec; 9(6):945-56. PubMed ID: 11177609 [TBL] [Abstract][Full Text] [Related]
14. [Studies on hematopoietic reconstitution by ex vivo expanded human cord blood hematopoietic stem/progenitor cells in SCID mice]. Liu Y; Pei X; Lu S Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):634-6. PubMed ID: 11721365 [TBL] [Abstract][Full Text] [Related]
15. Cobblestone area-forming cells, long-term culture-initiating cells and NOD/SCID repopulating cells in human neonatal blood: a comparison with umbilical cord blood. Zhang XB; Li K; Fok TF; Li CK; James AE; Lam AC; Lee SM; Yuen PM Bone Marrow Transplant; 2002 Nov; 30(9):557-64. PubMed ID: 12407429 [TBL] [Abstract][Full Text] [Related]
16. Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines. Grassinger J; Mueller G; Zaiss M; Kunz-Schughart LA; Andreesen R; Hennemann B Eur J Haematol; 2006 Aug; 77(2):134-44. PubMed ID: 16856909 [TBL] [Abstract][Full Text] [Related]
17. Small peptide analogue of SDF-1alpha supports survival of cord blood CD34+ cells in synergy with other cytokines and enhances their ex vivo expansion and engraftment into nonobese diabetic/severe combined immunodeficient mice. Li K; Chuen CK; Lee SM; Law P; Fok TF; Ng PC; Li CK; Wong D; Merzouk A; Salari H; Gu GJ; Yuen PM Stem Cells; 2006 Jan; 24(1):55-64. PubMed ID: 16123381 [TBL] [Abstract][Full Text] [Related]
18. [Cord blood transplantation and ex vivo expansion of hematopoietic stem cells]. Nakahata T Rinsho Byori; 1999 May; Suppl 110():54-62. PubMed ID: 10475032 [TBL] [Abstract][Full Text] [Related]
19. Hematopoietic repopulating ability of cord blood CD34(+) cells in NOD/Shi-scid mice. Ueda T; Yoshino H; Kobayashi K; Kawahata M; Ebihara Y; Ito M; Asano S; Nakahata T; Tsuji K Stem Cells; 2000; 18(3):204-13. PubMed ID: 10840074 [TBL] [Abstract][Full Text] [Related]
20. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice. Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]